Pesticide-induced scleroderma and early intensive immunosuppressive treatment

Archives of Environmental and Occupational Health

Volumn 67, Issue 1, 2012, Pages 43-47

  Sozeri, Betul ^a   Gulez, Nesrin ^a   Aksu, Guzide ^a   Kutukculer, Necil ^a   Akalin, Taner ^a   Kandiloglu, Gulsen ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Anti kinetochore; Anti topoisomerase; Children; Dichlorophenyl; Dimethyl ethyl; Diniconazole; Malathion; Pesticide; Phosphorodithioate; Scleroderma

Indexed keywords

ANTINUCLEAR ANTIBODY; AZINPHOS ETHYL; CENTROMERE ANTIBODY; DINICONAZOLE; IMMUNOGLOBULIN; MALATHION; METHOTREXATE; METHYLPREDNISOLONE; PESTICIDE; PREDNISOLONE; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT; TRIAZOLE DERIVATIVE;

ADOLESCENT; AGRICULTURAL WORKER; ARTHRALGIA; ARTICLE; CASE REPORT; CHILD; EXPOSURE; FACE; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIMB; LYMPHOCYTIC INFILTRATION; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; SCLERODERMA; SCLEROSIS; SKIN BIOPSY; SWELLING; TREATMENT DURATION; TREATMENT RESPONSE; TRUNK; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; LOCALIZED SCLERODERMA; SYSTEMIC SCLEROSIS;

ADOLESCENT; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALATHION; MALE; PESTICIDES; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; TRIAZOLES;

EID: 84859738621     PISSN: 19338244     EISSN: None     Source Type: Journal    
DOI: 10.1080/19338244.2011.564231     Document Type: Article

References (26)

1. Foti R, Leonardi R, Rondinoone R, et al. Scleroderma like disorders. Autoimmun Rev. 2008;7:331-339.
2. Boin F, Hummers LK. Scleroderma-like fibrosing disorders. Rheum Dis Clin North Am. 2008;34:199-220. (Pubitemid 351350629)
3. Kikuchi M, Inagaki T. Bibliographical study of the concurrent existence of anticentromere and antitopoisomerase I antibodies. Clin Rheumatol. 2000;19:435-441. (Pubitemid 32039662)
4. Bovenzi M, Barbone F, Pisa FE, et al. A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health. 2004;77:10-16. (Pubitemid 38094416)
5. Erasmus LD. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr Lab Clin Med. 1957;3:209-231.
6. Bovenzi M, Barbone F, Bettav A, et al. Scleroderma and occupational exposure. Scand J Work Environ Health. 1995;21:289-292.
7. Netert PJ, Sutherland SE, Silver RM, et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998;41:1111-1118. (Pubitemid 28265413)
8. Kamel F, Hoppin JA. Association of pesticide exposure with neurologic dysfunction and disease. Environ Health Perspect. 2004;112:950-958. (Pubitemid 38931102)
9. Firestone JA, Smith-Weller T, Franklin G, Swanson P, Longstreth WT Jr, Checkoway H. Pesticides and risk of Parkinson disease: a populationbased case-control study. Arch Neurol. 2005;62:91-95. (Pubitemid 40105040)
10. Farrant PB, Mortimer PS, Gore M. Scleroderma and the taxanes. Is there really a link? Clin Exp Dermatol. 2004;29:360-362. (Pubitemid 38980362)
11. Mora GF. Systemic sclerosis: environmental factors. J Rheumatol. 2009;36:2383-2396.
12. Aksu G, Gulez N, Azarsiz E, Karaca N, Kutukculer N. Determination of cut-off titers and agreement between immunofluorescence and immunoblotting methods for detecting antinuclear antibodies in children. J Clin Lab Anal. 2010;24:230-236.
13. Nietert PJ, Silver RM. Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol. 2000;12:520-526.
14. Veltman G, Lange CE, Juhe S, Stein G, Bachner U. Clinical manifestations and course of vinyl chloride disease. Ann N Y Acad Sci. 1975;246:6-17.
15. Toxic Epidemic Syndrome Study Group. Toxic epidemic syndrome, Spain, 1981. Lancet. 1982;2:697-702.
16. Hertzman PA, BlevinsWL, Mayer J, et al. Association of the eosinophiliamyalgia syndrome with the ingestion of tryptophan. N Engl J Med. 1990;322:869-873. (Pubitemid 20108375)
17. Diot E, Lesire V, Guilmot JL, et al. Systemic sclerosis and occupational risk factors: case-control study. Occup Environ Med. 2002;59:545-549. (Pubitemid 34864549)
18. Itoh M, Yanaba K, Kobayashi T, Nakagawa H. Taxane-induced scleroderma. Br J Dermatol. 2007;156:363-367. (Pubitemid 46095967)
19. Stinco G, Piccirillo F, de Francesco F, Patrone P. Scleroderma like lesions and Parkinson's disease: possible links with exposure to pesticides. Eur J Dermatol. 2007;17:256-257. (Pubitemid 46847803)
20. Dunnill MG, Black MM. Sclerodermatous syndrome after occupational exposure to herbicides-response to systemic steroids. Clin Exp Dermatol. 1994;19:518-520.
21. Antoccia A, Degrassi F, Battistoni A, Ciliutti P, Tanzarella C. In vitro micronucleus test with kinetochore staining: evaluation of test performance. Mutagenesis. 1991;6:319-324.
22. Gorbsky GJ, Ricketts WA. Differential expression of a phosphoepitope at the kinetochores of moving chromosomes. J Cell Biol. 1993;122:1311-1321. (Pubitemid 23277300)
23. Gwinn MR, Whipkey DL, Tennant LB, Weston A..Differential gene expression in normal human mammary epithelial cells treated with malathion monitored by DNA microarrays. Environ Health Perspect. 2005;113:1046-1051. (Pubitemid 41149636)
24. Li Z, Wu T, Li Q, Zhang B, Wang W, Li J. Characterization of racemization of chiral pesticides in organic solvents and water. J Chromatogr A. 2010;1217:5718-5723.
25. Altomonte A, Zoli A, Galossi A, et al. Scleroderma-like disease following occupational exposure to organic solvents. Clin Rheumatol. 1996;15:416-417.
26. Scalapino K, Arkachaisri T, Lucas M, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol. 2006;33: 1004-1013.